CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
AUTOR(ES)
Monteagudo, C
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955073Documentos Relacionados
- The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis
- Regulation of pulmonary fibrosis by chemokine receptor CXCR3
- The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
- Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.
- Primary cutaneous melanoma: an 18-year study